Pfizer

Pharmaceuticals
PFE
$ 30 (1.5)%
Share price
$ 168 bn
Market Cap
$ 190 bn
Enterprise Value

Carbon footprint

6 Ton
GHG emissions per $ 1 mln investment
0.17x the weighted average for S&P 500
FY2022
How is this calculated?
-0.9%
YOY change in GHG emissions
Weaker than the +0.5% weighted average for S&P 500
FY2022 vs. previous year

Primary Climate Goal

-4.9%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -8.2% weighted average for S&P 500
FY2023
How is this calculated?

Pfizer aims to reduce Scope 1 + 2 by 46% by 2030 from a base year 2019


1.5°C
Pfizer's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Pfizer's GHG emissions (market-based) (Kt of CO2e)
Pfizer's Carbon intensity (Tons per 1 USDm)

Pfizer's carbon footprint

Pfizer reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2022 at 1,140 Kt (-10 /-0.9% y-o-y). Also positively, carbon intensity plunged to 28 t (-3.4 /-10.9% y-o-y).

Pfizer's Scope 3 emissions rose to 4,755 Kt (+1,081/+29% y-o-y). The time series has been volatile over the last few periods.

The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -56 Kt per annum over the period of FY2023 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Company environmental metrics

Show more...